Possible Denominator Codes Applicable to OMS * Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, 21436

Size: px
Start display at page:

Download "Possible Denominator Codes Applicable to OMS * Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, 21436"

Transcription

1 2015 Individual PQRS s Eligible OMS #22: Perioperative Care: Discontinuation of Prophylactic Antibiotics (Non- Cardiac Procedures) Percentage of noncardiac surgical patients aged 18 years and older undergoing procedures with the indications for prophylactic parenteral antibiotics who received a prophylactic parenteral antibiotic, who have an order for discontinuation of prophylactic parenteral antibiotics within 24 hours of surgical end time Having one of the non-cardiac surgical procedures for which prophylactic parenteral antibiotics are indicated. Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, Mandibular Fractures 21454, 21461, 21462, 21465, Glossectomy 41130, 41135, 41140, 41145, 41150, 41153, Non-cardiac surgical patients who have an order for discontinuation of prophylactic parenteral antibiotics within 24 hours of surgical end time Documentation of Order for Discontinuation of Prophylactic Parenteral Antibiotics (written order, verbal order, or standing order/protocol) Within 24 Hours of Surgical End Time (Two CPT II codes [4049F & 4046F] are required on the claim form to submit this numerator option) CPT II 4049F: Documentation that order was given to discontinue prophylactic antibiotics within 24 hours of surgical end time, non-cardiac procedure Note: CPT Category II code 4049F is provided for documentation that antibiotic discontinuation was ordered or that antibiotic discontinuation was accomplished. Report CPT Category II code 4049F if antibiotics were discontinued within 24 hours. CPT II 4046F: Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or given intraoperatively Prophylactic Parenteral Antibiotics not Discontinued for Medical Reasons (Two CPT II codes [4049F-1P & 4046F] are required on the claim form to submit this numerator option) Append a modifier (1P) to CPT Category II code 4049F to report documented circumstances that appropriately exclude patients from the denominator. 4049F with 1P: Documentation of medical reason(s) for not discontinuing prophylactic antibiotics within 24 hours of surgical end time

2 CPT II 4046F: Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or given intraoperatively If patient is not eligible for this measure because patient did not receive prophylactic parenteral antibiotics within specified timeframe, report: (One CPT II code [4042F] is required on the claim form to submit this numerator option) CPT II 4042F: Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor given intraoperatively Prophylactic Parenteral Antibiotics not Discontinued, Reason not Specified (Two CPT II codes [4049F-8P & 4046F] are required on the claim form to submit this numerator option) Append a reporting modifier (8P) to CPT Category II code 4049F to report circumstances when the action described in the numerator is not performed and the reason is not otherwise specified. 4049F with 8P: Order was not given to discontinue prophylactic antibiotics within 24 hours of surgical end time, non-cardiac procedure, reason not otherwise specified #23: Perioperative Care: Venous Le Fort Fractures 21346, 21347, 21348, 21422, Surgical patients who had an order for CPT II 4046F: Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or given intraoperatively CPT II 4044F: Documentation that an order was given for venous thromboembolism (VTE) prophylaxis to be given within 24 hours prior to incision time or 24 hours after surgery end time

3 #46: Thromboembolism (VTE) Prophylaxis Percentage of surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients, who had an order for Low Molecular Weight Heparin (LMWH), Low- Dose Unfractionated Heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time Medication Reconciliation: Reconciliation After Discharge from an Inpatient Facility Percentage of patients aged 65 years and older discharged from any inpatient facility (eg, hospital, skilled nursing facility, or rehabilitation facility) and seen within 60 days following discharge in the office by the physician providing on-going care who had a reconciliation of the discharge, GPRO the s 65 years on the s 21423, 21432, 21433, 21435, Mandibular Fractures 21454, 21461, 21462, 21465, Glossectomy 41130, 41135, 41140, 41145, 41150, 41153, , 99204, 99205, 99212, 99213, 99214, 99215, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, LMWH, LDUH, adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time had a reconciliation of the discharge medications with the current medication list in the outpatient medical record documented 4044F with 1P: Documentation of medical reason(s) for patient not receiving any form of VTE prophylaxis (LMWH, LDUH, adjusted-dose warfarin, fondaparinux or mechanical prophylaxis) within 24 hours prior to incision time or 24 hours after surgery end time 4044F with 8P: Order was not given for venous thromboembolism (VTE) prophylaxis to be given within 24 hours prior to incision time or 24 hours after surgery end time, reason not otherwise specified Documentation of Reconciliation of Discharge Medication with Current Medication List in the Medical Record (CPT II code [1111F] is required on the claim form to submit this numerator option) CPT II 1111F: Discharge medications reconciled with the current medication list in outpatient medical record If patient is not eligible for this measure because patient was not discharged from an inpatient facility within the last 60 days, there are no reporting requirements in this case. Discharge Medication not Reconciled with Current Medication List in the Medical Record, Reason Not Specified

4 medications with the current medication list in the medical record documented (Two CPT II codes [1111F-8P & 1110F] are required on the claim form to submit this numerator option) Append a reporting modifier (8P) to CPT Category II code 1111F to report circumstances when the action described in the numerator is not performed and the reason is not otherwise specified. 1111F with 8P: Discharge medications not reconciled with the current medication list in outpatient medical record, reason not specified #47 Advanced Care Plan, EHR Patients aged > 65 years on Having one of the s during the reporting period 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99218, 99219, 99220, 99221, 99222, 99223, 99231, 99232, 99234, 99235, 99236, 99291, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0402 have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan Advance Care Planning Discussed and Documented CPT II 1123F: Advance Care Planning discussed and documented; advance care plan or surrogate decision maker documented in the medical record CPT II 1124F: Advance Care Planning discussed and documented in the medical record; patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan Advance Care Planning not Documented, Reason not Otherwise Specified Append a reporting modifier (8P) to CPT Category II code 1123F to report circumstances when the action described in the numerator is not performed and the reason is not otherwise specified. 1123F with 8P: Advance care planning not documented, reason not otherwise specified

5 #130: #131: Documentation of Current Medications in the Medical Record: Percentage of specified visits for patients aged 18 years and older for which the eligible professional attests to documenting a list of current medications to the best of his/her knowledge and ability. This list must include ALL prescriptions, overthe-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements must contain the medications name, dosage, frequency and route of administration Pain Assessment and Follow-Up: Percentage of visits for patients aged 18 years and older with documentation of a pain assessment through discussion with the patient including the use of a standardized tool(s) on each visit documentation of a follow-up plan when pain is present the s the s 92610, 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, D7140, D , 96116, 96150, 97532, 99203, 99204, 99205, 99212, 99213, 99214, Patient documentation substantiates use of a certified, Physician Quality System qualified or other acceptable EHR system. NUMERAT NOTE: If an eligible professional does not use a qualified system to record the, they should not report any G-code. Current medications including name, dosages, frequency and route documented by the provider Encounter Documented Using a Certified, Physician Quality System Qualified or Other Acceptable EHR System G8447: Patient was documented using an EHR system that has been certified by an Authorized Testing and Certification Body (ATCB) G8448: Patient was documented using a Physician Quality System qualified EHR or other acceptable systems G8730: Pain assessment documented as positive utilizing a standardized tool and a followup plan is documented G8731: Pain assessment documented as negative, no follow-up plan required G8442: Documentation that patient is not eligible for a pain assessment

6 G8939: Pain assessment documented, follow-up plan not documented, patient not eligible/appropriate G8732: No documentation of pain assessment, reason not given #173 #193 Preventive Care and Screening: Unhealthy Alcohol Use- Screening: Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use at least once within 24 months using a systematic screening method Perioperative Temperature Management: Percentage of patients, regardless of age, undergoing surgical or therapeutic procedures under general or neuraxial anesthesia of the s All patients, regardless of age, undergoing surgical or therapeutic procedures under general or neuraxial 96150, 96151, 96152, 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, G0438, G , 99203, 99204, 99205, 99211, 99212, 99213, 99214, were screened for unhealthy alcohol use at least once within 24 months using a systematic screening method. Patients for whom either active warming was used intraoperatively for the purpose of maintaining normothermia G8509: Documentation of positive pain assessment; no documentation of a follow-up plan, reason not given 3016F: Patient screened for unhealthy alcohol use using a systematic screening method 3016F with 1P: Documentation of medical reasons for not screening for unhealthy alcohol use 3016F with 9P: Unhealthy alcohol use screening not performed, reason not otherwise specified 4250F: Active warming used intraoperatively for the purpose of maintaining normothermia, at least one body temperature equal to or greater than 36 degrees Centigrade (or 96.8 degrees Fahrenheit) recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time

7 # minutes duration or longer, except patients undergoing cardiopulmonary bypass, for whom either active warming was used intraoperatively for the purpose of maintaining normothermia, at least one body temperature equal to or greater than 36 degrees Centigrade (or 96.8 degrees Fahrenheit) was recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time Oncology: Cancer Stage Documented Percentage of patients, regardless of age, with a diagnosis of cancer who are seen in the ambulatory setting who have a baseline AJCC cancer stage or documentation that the cancer is metastatic in the medical record at least once within 12 months anesthesia of 60 minutes duration or longer, except patients undergoing cardiopulmonar y bypass All patients, regardless of age, with a diagnosis of cancer who are seen in the Ambulatory setting Having one or more of the s (ICD-9-CM, CPT codes) , , 160.0, 160.2, 160.3, , , 170.0, 170.1, 171.0, , , , 77261, 77262, 77263, 99201, 99202, 99203, 99204, 99205, at least one body temperature equal to or greater than 36 degrees Centigrade (or 96.8 degrees Fahrenheit) was recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time have a baseline American Joint Committee on Cancer (AJCC) cancer stage or documentation that the cancer is metastatic in the medical record at least once within the 12 month reporting period 4255F: Duration of general or neuraxial anesthesia 60 minutes or longer, as documented in the anesthesia record 4256F: Duration of general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record Cancer Stage Documented and Reviewed CPT II 3300F: American Joint Committee on Cancer (AJCC) stage documented and reviewed CPT II 3301F: Cancer stage documented in medical record as metastatic and reviewed Cancer Stage not Documented, Reason not Otherwise Specified Append a reporting modifier (8P) to CPT Category II code 3301F to report circumstances when the action described in the numerator is not performed and the reason is not otherwise specified. 3301F with 8P: Cancer stage not documented, reason not otherwise specified

8 # 226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months who received cessation counseling intervention if identified as a tobacco user, EHR, GPRO the s 99212, 99213, 99214, , 99204, 99205, 99212, 99213, 99214, were screened for tobacco use at least once within 24 months who received tobacco cessation counseling intervention if identified as a tobacco user Patient Screened for Tobacco Use CPT II 4004F: Patient screened for tobacco use received tobacco cessation counseling, if identified as a tobacco user Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco CPT II 1036F: Current tobacco non-user Tobacco Screening not Performed for Medical Reasons Append a modifier (1P) to CPT Category II code 4004F to report documented circumstances that appropriately exclude patients from the denominator 4004F with 1P: Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy) #265 Biopsy Follow-Up: Percentage of new patients whose biopsy results have been reviewed and communicated to the All patients undergoing a biopsy 11100, 20200, 20205, 20206, 20220, 20225, 20240, 20245, 30100, 31050, se biopsy results have been reviewed and communicated Tobacco Screening not Performed Reason Not Specified Append a reporting modifier (8P) to CPT Category II code 4004F to report circumstances when the action described in the numerator is not performed and the reason is not otherwise specified. 4004F with 8P: Tobacco Screening not performed, reason not otherwise specified G8883: Biopsy results reviewed, communicated, tracked and documented G88884:Clinician documented reason that patient s biopsy results were not reviewed, [e.g.,

9 #317 primary care/referring physician and patient by the performing physician Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented Percentage of patients aged 18 years and older seen during the reporting period who were screened for high blood pressure a recommended follow-up plan is documented based on the current the s 31051, 38500, 38505, 40490, 40808, 41100, 41108, 42100, 42400, 42405, 42800, 42802, 42804, 42806, 64795, 99201, 99202, 99203, 99204, , 99204, 99205, 99212, 99213, 99214, 99215, 99218, 99219, 99220, 99224, 99225, 99226, 99234, 99235, 99236, 99281, 99282, 99283, 99285, D7140, D7210, G0101, G0402, G0438, G0429 to the primary care/referring physician and the patient by the physician performing the biopsy. The physician performing the biopsy must also acknowledge and/or document the communication in a biopsy tracking log and document in the patient s medical record. were screened for high blood pressure have a recommended follow-up plan documented, as indicated if the blood pressure is prehypertensive or hypertensive patient asks that biopsy results not be communicated to the primary care/referring physician, patient does not have a primary care/referring physician or is a self-referred patient] G8885: Biopsy results NOT reviewed, communicated, tracked or documented G8783: Normal blood pressure reading documented, follow-up not required G8950: Pre-Hypertensive or Hypertensive blood pressure reading documented, the indicated follow-up is documented G8784: Blood pressure reading not documented, documentation the patient is not eligible G8951: Pre-Hypertensive or Hypertensive blood pressure reading documented, indicated followup not documented, documentation the patient is not eligible

10 #332 blood pressure (BP) reading as indicated Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin Prescribed for Patients with Acute Bacterial Sinusitis Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a Diagnosis for acute sinusitis [for 1/1/2014-9/30/2014]: 461.0, 461.1, 99204, 99205, 99212, 99213, 99214, 99215, 99281, 99282, 99283, 99284, NUMERAT NOTE: Although the recommended screening interval for a normal BP reading is every 2 years, to meet the intent of this measure, a BP screening must be performed once per measurement period. The intent of this measure is to screen patients for high blood pressure and provide recommended follow-up as indicated. Normal blood pressure follow-up is not recommended for patients with clinical or symptomatic hypotension. were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosis G8785: Blood pressure reading not documented, reason not given G8952: Pre-Hypertensive or Hypertensive blood pressure reading documented, indicated followup not documented, reason not given G9315: Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis G9313: Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason (e.g., cystic fibrosis, immotile cilia disorders, ciliary dyskinesia, immune deficiency, prior history of sinus surgery within the past 12 months, and anatomic abnormalities, such as deviated nasal septum, resistant organisms, allergy to medication, recurrent sinusitis, chronic sinusitis, or other reasons)

11 first line antibiotic at the time of diagnosis 461.2, 461.3, 461.8, Diagnosis for acute sinusitis (ICD-10-CM) [for 10/01/ /31/2014]: J01.00, J01.10, J01.20, J01.30, J01.40, J01.80, J01.90 G9314: Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given the s #333 Adult Sinusitis: Computed Tomography (CT) for Acute Sinusitis (Overuse): Percentage of patients aged 18 years and older with a diagnosis of acute sinusitis who had a Diagnosis for acute sinusitis 99204, 99205, 99212, 99213, 99214, 99215, 99281, 99282, 99283, 99284, had a computerized tomography (CT) scan of the paranasal sinuses ordered at the time of diagnosis or G9349: CT scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after diagnosis G9348: CT scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons (e.g., persons with sinusitis symptoms lasting at least 7 to 10 days, antibiotic resistance, immunocompromised, recurrent

12 computerized tomography (CT) scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis [for 1/1/2014-9/30/2014]: 461.0, 461.1, 461.2, 461.3, 461.8, Diagnosis for acute sinusitis (ICD-10-CM) [for 10/01/ /31/2014]: J01.00, J01.10, J01.20, J01.30, J01.40, J01.80, J01.90 received within 28 days after diagnosis sinusitis, acute frontal sinusitis, acute sphenoid sinusitis, periorbital cellulitis, or other medical) G9350: CT scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after diagnosis the s #334 Adult Sinusitis: More than one Computerized Tomography (CT) Scan Within , 99205, 99212, 99213, 99214, 99215, 99281, 99282, had more than one CT scan of the paranasal sinuses ordered or received G9352: More than one CT scan of the paranasal sinuses ordered or received within 90 days after the diagnosis, reason not given

13 Days for Chronic Sinusitis (Overuse): Percentage of patients aged 18 years and older with a diagnosis of chronic sinusitis who had more than one CT scan of the paranasal sinuses ordered or received within 90 days after diagnosis Diagnosis for acute sinusitis [for 1/1/2014-9/30/2014]: 461.0, 461.1, 461.2, 461.3, 461.8, Diagnosis for acute sinusitis (ICD-10-CM) [for 10/01/ /31/2014]: J01.00, J01.10, J01.20, J01.30, J01.40, J01.80, J , 99284, within 90 days after diagnosis G9353: More than one CT scan of the paranasal sinuses ordered or received within 90 days after the diagnosis for documented reasons (e.g., patients with complications, second CT obtained prior to surgery, other medical reasons) G9354: One CT scan or no CT scan of the paranasal sinuses ordered within 90 days after the diagnosis the s #342 Pain Brought Under Control Within 48 Hours: 18 years 99324, 99325, 99326, 99337, G0182 se pain was brought to a G9250: Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

14 Patients aged 18 and older who report being uncomfortable because of pain at the initial assessment (after admission to palliative care services) who report pain was brought to a comfortable level within 48 hours the s comfortable level within 48 hours of initial assessment (after admission to palliative care services) G9251: Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment Patient able to communicate and understand the language of the person asking #402 Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Patient selfreported uncomfortable due to pain at the initial assessment Patients aged 1220 years on the 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99406, 99407, were screened for tobacco use at least once within 18 months (during the G9458: Patient documented as tobacco user received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco

15 Community / Population Health Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health the s measurement period or the six months prior to the measurement period) who received tobacco cessation counseling intervention if identified as a tobacco user use cessation program) if identified as a tobacco user G9459: Currently a tobacco non-user G9460: Tobacco assessment tobacco cessation intervention not performed, reason not otherwise specified CMS has established the QualityNet Help Desk as a resource for those with questions on PQRS reporting. They can be reached at or qnetsupport@sdps.org from 7:00 a.m. 7:00 p.m. CST.

16

Individual Quality Measures Applicable to Eligible OMS-MPFS Final Rule 2019

Individual Quality Measures Applicable to Eligible OMS-MPFS Final Rule 2019 Individual s Applicable to Eligible OMS-MPFS Final Rule 2019 Indicator* Codes (Patient Safety #21: Perioperative Care: Selection of Prophylactic Antibiotic First Second Generation Cephalospori n National

More information

The NOF & NBHA Quality Improvement Registry

The NOF & NBHA Quality Improvement Registry In collaboration with CECity The NOF & NBHA Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO Practices for

More information

2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

Non-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys

Non-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended

More information

creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed

creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended

More information

Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)

Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) 2013 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

Non-QPP Measures 3 AQUA12. 6 AQUA15 Stones: Urinalysis documented 30 days before

Non-QPP Measures 3 AQUA12. 6 AQUA15 Stones: Urinalysis documented 30 days before Non-QPP Measures 1 Measure ID Measure Title Definition Type Domain AQUA3 (inverse) Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age

More information

Percentage of patients who underwent endoscopic procedures following SWL

Percentage of patients who underwent endoscopic procedures following SWL Non-QPP Measures Measure ID Measure Title Definition Type Domain 1 AQUA12 Benign Prostate Hyperplasia: IPSS improvement after diagnosis Percentage of patients with NEW diagnosis of clinically significant

More information

2016 Cross-Cutting Measure Set

2016 Cross-Cutting Measure Set 1 0059 Diabetes: Hemoglobin A1c Poor Control: Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the 46 0097 Claims, Registry Medication Reconciliation Post Discharge:

More information

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1 1 CQ-IQ covers 65 CMS defined measures that Eligible Providers (EPs) have to report on to assess quality of care provided to the patients. Version Supported: PQRS Registry 2015 65 measures Reporting Period:

More information

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET PQRS in TRAKnet 2015 GUIDE TO SUBMITTING AND REPORTING PQRS IN 2015 THROUGH TRAKNET What is PQRS? PQRS is a quality reporting program that uses negative payment adjustments to promote reporting of quality

More information

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593 Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2015 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

Compass PTN Core Measures

Compass PTN Core Measures Compass PTN Core Measures emeasure ID: CMS122v5 NQF: 0059 QualityID: 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) Patients 18-75 years of age with diabetes with a visit during the measurement

More information

DataDerm Quality Measures

DataDerm Quality Measures 01 MIPS 224 NQF 0562 DataDerm Quality s Melanoma: Overutilization of Imaging Studies 02 a & b MIPS 138 Melanoma: Coordination of Care 03 MIPS 137 NQF 0650 Melanoma: Continuity of Care Recall System Percentage

More information

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) National Quality Strategy

More information

2017 Data Collection Form: Orthopedics Advanced

2017 Data Collection Form: Orthopedics Advanced 2017 Data Collection Form: Orthopedics Advanced Physician Name: The following Quality measures are included in this ADVANCED specialty set: o 21 Perioperative - Selection of Prophylactic Antibiotic o 23

More information

2014 Oncology Measures Group Overview

2014 Oncology Measures Group Overview 2014 Oncology Measures Group Overview The Oncology Measures Group is a reporting option that significantly reduces the burden of participation in the Physician Quality Reporting System (PQRS). Source:

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #22 (NQF 0271): Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Non-Cardiac Procedures) National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

2016 Internal Medicine Preferred Specialty Measure Set

2016 Internal Medicine Preferred Specialty Measure Set 1 0059 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period 5 0081 Registry, EHR, 9 0105

More information

CMS-5522-FC TABLE C.1: MIPS Measures Finalized for Removal Only from Specialty Sets for the 2018 Performance Period and Future Years

CMS-5522-FC TABLE C.1: MIPS Measures Finalized for Removal Only from Specialty Sets for the 2018 Performance Period and Future Years CMS-5522-FC 1569 MIPS s Finalized for Removal Only from Sets for the 2018 Performance Period and Future Years Note: In the CY 2018 Payment Program proposed rule (82 FR 30455 through 30462), CMS proposed

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

2016 General Practice/Family Practice Preferred Specialty Measure Set

2016 General Practice/Family Practice Preferred Specialty Measure Set 1 0059 5 0081 41 N/A 50 N/A 65 0069, EHR 66 0002, EHR Effective Clinical Care Effective Clinical Care Effective Clinical Care Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients

More information

Date Modified: March 31, Clinical Quality Measures for PQRS

Date Modified: March 31, Clinical Quality Measures for PQRS Date Modified: March 31, 2015 2015 Clinical Quality s for PQRS # Domain Title Description Type Denominator Numerator Denominator Exclusions/Exceptions 1 Patient Safety Prostate Biopsy Antibiotic Process

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

The Renal Physicians Association Quality Improvement Registry

The Renal Physicians Association Quality Improvement Registry In collaboration with CECity The Renal Physicians Association Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO

More information

March 31, Dear colleagues,

March 31, Dear colleagues, 6300 North River Road Rosemont, IL 60018 p: 847-292-0530 f: 847-292-0531 www.ajrr.net March 31, 2014 Dear colleagues, The American Joint Replacement Registry (AJRR) has submitted materials to be considered

More information

2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement

2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement 2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory reporting.

More information

SINUSITIS MEASURES GROUP OVERVIEW

SINUSITIS MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: SINUSITIS MEASURES GROUP OVERVIEW 2015 PQRS MEASURES IN SINUSITIS MEASURES GROUP: #130 Documentation of Current Medications in the Medical Record #131 Pain Assessment

More information

2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse

More information

SINUSITIS MEASURES GROUP OVERVIEW

SINUSITIS MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: SINUSITIS MEASURES GROUP OVERVIEW 2016 PQRS MEASURES IN SINUSITIS MEASURES GROUP: #130 Documentation of Current Medications in the Medical Record #131 Pain Assessment

More information

QUALIFIED CLINICAL DATA REGISTRY (QCDR) 2017 MEASURE SPECIFICATIONS

QUALIFIED CLINICAL DATA REGISTRY (QCDR) 2017 MEASURE SPECIFICATIONS QOPI5 Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Percentage of adult patients with metastatic solid tumors

More information

2017 Merit-based Incentive Payment System. Avoiding the Penalty

2017 Merit-based Incentive Payment System. Avoiding the Penalty 2017 Merit-based Incentive Payment System Avoiding the Penalty 1 What is the Quality Reporting Program? Quality Payment Program (also known as MACRA) Advanced Alternative Payment Models (APMs) Merit-based

More information

MEASURE SPECIFICATIONS

MEASURE SPECIFICATIONS QOPI REPTING REGISTRY (QCDR) 2018 QOPI 5 QOPI 11 Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Combination chemotherapy

More information

2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) 2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Medical Record

More information

IQSS 2019 QCDR and MIPS Measure Specifications

IQSS 2019 QCDR and MIPS Measure Specifications IQSS1 Hypogonadism: Serum T, CBC, PSA, IPSS within 6 months of Rx Percentage of patients with a Effective Clinical Patients with documented new diagnosis of hypogonadism receiving androgen replacement

More information

Physician Quality Reporting System 2016

Physician Quality Reporting System 2016 KEEP CALM AND REPORT ON! Physician Quality Reporting System 2016 As nervous about their Physician the calendar year 2016 begins, many providers may be getting Quality Reporting System (PQRS) participation.

More information

NOF & NBHA Quality Improvement Registry in collaboration with CECity (NOF)

NOF & NBHA Quality Improvement Registry in collaboration with CECity (NOF) Number of Non- s submitted by QCDR: 15 NON - Title Description NQS Domain NQF Number ecqm Number NOF 1 Laboratory Investigation for Secondary Percentage of patients age 50 and over with fragility Effective

More information

MEASURE SPECIFICATIONS

MEASURE SPECIFICATIONS QOPI REPTING REGISTRY (QCDR) 2018 QOPI5 Title Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Description Percentage

More information

PCMH 2018 Enrollment and Update August 25, 2017

PCMH 2018 Enrollment and Update August 25, 2017 PCMH 2018 Enrollment and Update August 25, 2017 Enrollment Requirements Anne Santifer HealthCare Innovations Department of Human Services 2018 Enrollment Requirements A physician practice that is enrolled

More information

2011 Physician Quality Reporting System Measures for Consideration by Oncology Providers: Cancer Care Measures

2011 Physician Quality Reporting System Measures for Consideration by Oncology Providers: Cancer Care Measures 2011 Physician Quality Reporting System Measures for Consideration by Oncology Providers: Cancer Care Measures The table below includes measures directly relevant to oncology providers as well as general

More information

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MEASURES GROUP OVERVIEW

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MEASURES GROUP OVERVIEW CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: 2016 PQRS MEASURES IN COPD MEASURES GROUP: #47 Care Plan #51 Chronic Obstructive Pulmonary Disease

More information

Controlled IOP Uncontrolled IOP Diabetes with or without retinopathy

Controlled IOP Uncontrolled IOP Diabetes with or without retinopathy PQRS Guidelines I. Introduction A. The reporting of these additional codes are used to determine the quality of care a provider gives to patients with certain diseases. B. All PQRS codes including the

More information

Documentation Tips for Quality Measures

Documentation Tips for Quality Measures Documentation Tips for Quality Measures Electronic health records (EHRs) collect and organize notes, medication lists, and patient information using various formats. With providers also documenting this

More information

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents Comprehensive ESRD Care (CEC) Model Proposed Quality s for Public Comment Table of Contents Page # Introduction 3 Summaries by Domain Technical Expert Panel Recommended CEC Quality s 4 s that were recommended

More information

PracticePerspectives. Winter. Reporting PQRS Measures for Medicare in Mirean Coleman, The National Association of Social Workers

PracticePerspectives. Winter. Reporting PQRS Measures for Medicare in Mirean Coleman, The National Association of Social Workers I S S U E Winter M A R C H 2 0 1 3 PracticePerspectives The National Association of Social Workers 750 First Street NE Suite 700 Washington, DC 20002-4241 SocialWorkers.org Mirean Coleman, MSW, LICSW,

More information

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures)

More information

2018 MIPS Reporting Family Medicine

2018 MIPS Reporting Family Medicine 2018 MIPS Reporting Family Medicine Quality Reporting Requirements: Report on 6 quality measures or a specialty measure set Include at least ONE outcome or high-priority measure Report on patients of All-Payers

More information

Date Modified: May 29, Clinical Quality Measures for PQRS

Date Modified: May 29, Clinical Quality Measures for PQRS Date Modified: May 29, 2014 Clinical Quality s for PQRS # Domain Type Denominator Numerator Denominator Exclusions/Exceptions Rationale QCDR-1 QCDR-2 Patient Safety 102 Efficiency and Cost Reduction QCDR-3

More information

NOA 3rd Party Newsletter PQRS EDITION - Page 1 CONTENTS. Traffic Sheet P.3. Flowsheet & Detailed Directions P.11.

NOA 3rd Party Newsletter PQRS EDITION - Page 1 CONTENTS. Traffic Sheet P.3. Flowsheet & Detailed Directions P.11. NOA 3rd Party Newsletter - 2016 PQRS EDITION - Page 1 CONTENTS EYE MEASURES Measure #12 :Primary Open-Angle Glaucoma: Optic Nerve Evaluation Traffic Sheet P.2. Flowsheet & Detailed Directions P.8. Measure

More information

AMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures:

AMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures: AMI Provide appropriate treatment to Acute MI patients with these core measures: Aspirin received within 24 hours of arrival or contraindication documented Primary PCI Received Within 90 Minutes of Hospital

More information

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding

More information

Practice-Level Executive Summary Report

Practice-Level Executive Summary Report PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular

More information

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

Measures Groups Specifications Manual

Measures Groups Specifications Manual 2015 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual Utilized by Individual Eligible Professionals Registry ONLY Reporting 12/22/2014 This manual contains specific guidance

More information

2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) 2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory

More information

Hospital OQR Quality Measures and Timelines for CY 2015 and Subsequent Payment Determinations

Hospital OQR Quality Measures and Timelines for CY 2015 and Subsequent Payment Determinations OQR Quality Measures and Timelines for CY 2015 and Subsequent Payment Determinations Data collection, implementation, and public reporting information for each measure are detailed by measure set in the

More information

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0 Consensus Core Set: ACO and PCMH / Primary Care s 0018 Controlling High Blood Pressure patients 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

Hepatitis C (HCV) Digestive Health Recognition Program

Hepatitis C (HCV) Digestive Health Recognition Program PQRS #84 Hepatitis C: Ribonucleic Acid (RNA) Effective Clinical Process NQF 0395 Testing Before Initiating Treatment Care Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis

More information

Trauma Measure #3 Venous Thromboembolism (VTE) Prophylaxis in Abdominal Trauma. National Quality Strategy (NQS) Domain: Patient Safety

Trauma Measure #3 Venous Thromboembolism (VTE) Prophylaxis in Abdominal Trauma. National Quality Strategy (NQS) Domain: Patient Safety Trauma Measure #3 Venous Thromboembolism (VTE) Prophylaxis in Abdominal Trauma National Quality Strategy (NQS) Domain: Patient Safety Measure Type (Process/Outcome): Process 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

Do Not Cite. Draft for Work Group Review.

Do Not Cite. Draft for Work Group Review. Defect Free Acute Inpatient Ischemic Stroke Measure Bundle Measure Description Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke OR transient ischemic attack who were admitted

More information

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY

More information

Specifications Manual Update: Hospital Outpatient Quality Reporting (OQR) Program

Specifications Manual Update: Hospital Outpatient Quality Reporting (OQR) Program Specifications Manual Update: Hospital Outpatient Quality Reporting (OQR) Program Melissa Thompson, RN, BSN Specifications Manual Lead Hospital OQR Program Support Contractor January 23, 2019 Featuring:

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #334: Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) National Quality Strategy

More information

Oncology Quality Clinical Data Registry

Oncology Quality Clinical Data Registry Oncology Quality Clinical Data Registry Powered by Premier Inc. This registry has been approved by CMS as a Qualified Clinical Data Registry (QCDR) for eligible clinicians and group practices for the 2019

More information

2012 Core Measures. Acute Myocardial Infarction (AMI)

2012 Core Measures. Acute Myocardial Infarction (AMI) 2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO ACO-1 ACO-2 Getting Timely Care, Appointments, and Information How Well Your Providers

More information

Tobacco Use: Screening & Cessation Intervention

Tobacco Use: Screening & Cessation Intervention Tobacco Use: Screening and Cessation Intervention MSSP ACO Measure Tobacco Use: Screening & Cessation Intervention Domain: Preventive Care and Screening ACO 17 PREV- 10 PQRS - 226 NQF 0028 Measure Steward:

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY

More information

2017 MSSP Clinical Quality Measures

2017 MSSP Clinical Quality Measures *The information contained in this document relies heavily on information supplied by CMS. GPRO CARE-1 (NQF 0097): Medication Reconciliation Post-Discharge DESCRIPTION: Percentage of discharges from any

More information

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: Percentage of new patients whose

More information

2016 Physician Quality Reporting System Data Collection Form: Multiple Chronic Conditions (for patients aged 66 and older)

2016 Physician Quality Reporting System Data Collection Form: Multiple Chronic Conditions (for patients aged 66 and older) 2016 Physician Quality Reporting System Data Collection Form: Multiple Chronic Conditions (for patients aged 66 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures)

More information

Quality Committee Core Measures Report AMI. Acute Myocardial Infarction

Quality Committee Core Measures Report AMI. Acute Myocardial Infarction AMI 2011 Acute Myocardial Infarction ASPIRIN AT ARRIVAL: A higher number is better. This measure shows the percentage of heart attack patients who receive aspirin within 24 hrs of arrival at hospital.

More information

UCLA Health System Apr - Jun 2013 (Q2)

UCLA Health System Apr - Jun 2013 (Q2) Denom Observed VBP Standard VBP Benchmark Denom Observed VBP Standard VBP Benchmark N Percent x/n N Percent x/n Value Based Purchasing-Clinical Process of Care Measures (%) SCIP-Inf-9 Urinary catheter

More information

ASTHMA MEASURES GROUP OVERVIEW

ASTHMA MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: ASTHMA MEASURES GROUP OVERVIEW 2016 PQRS MEASURES IN ASTHMA MEASURES GROUP: #53 Asthma: Pharmacologic Therapy for Persistent Asthma Ambulatory Care Setting #110 Preventive

More information

ASTHMA MEASURES GROUP OVERVIEW

ASTHMA MEASURES GROUP OVERVIEW ASTHMA MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN ASTHMA MEASURES GROUP: #53 Asthma: Pharmacologic Therapy for Persistent Asthma Ambulatory Care Setting #110 Preventive

More information

2016 PQRS Recommended Measures for: General/Family Practice

2016 PQRS Recommended Measures for: General/Family Practice Measures Groups Choose 1 Measures Group Report on a minimum of 20 eligible patients (at least 11 must be Medicare Part B FFS patients) #130: Documentation of Current Medications in the Medical Record #204:

More information

TABLE E: 2017 Finalized MIPS Specialty Measure Sets

TABLE E: 2017 Finalized MIPS Specialty Measure Sets TABLE E: 2017 Finalized MIPS Specialty Sets [Discussion of S approach to adding previously identified cross-cutting measures to specialty measure sets.] E- ID Title and Description Steward 1. Allergy/Immunology

More information

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use 2010 PQRI REPTING OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years or older who

More information

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT I S S U E Winter M A R C H 2 0 1 4 PracticePerspectives The National Association of Social Workers 750 First Street NE Suite 700 Washington, DC 20002-4241 SocialWorkers.org Mirean Coleman, LICSW, CT Senior

More information

SUNY Downstate Medical Center/University Hospital Oct - Dec 2013 (Q4)

SUNY Downstate Medical Center/University Hospital Oct - Dec 2013 (Q4) Value Based Purchasing-Clinical Process of Care Measures Denom Observed VBP VBP Benchmark Standard Denom Observed VBP VBP Benchmark Standard N Percent x/n N Percent x/n SCIP-Inf-9 Urinary catheter removed

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: 2016 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6 Coronary Artery Disease (CAD): Antiplatelet

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet

More information

Performance Outcomes: Measure & Metric Details

Performance Outcomes: Measure & Metric Details Performance Outcomes: Measure & Metric Details Adherence to Antipsychotic Medications for People with Schizophrenia Numerator: Number of people who remained on an antipsychotic for at least 80% of their

More information

MIPS: Quality Direct EHR Manual for Aprima Users

MIPS: Quality Direct EHR Manual for Aprima Users MIPS: Quality Direct EHR Manual for Aprima Users CONTENTS QUALITY INTRODUCTION... 5 CMS 2: SCREENING FOR CLINICAL DEPRESSION AND FOLLOWUP PLAN....6 CMS 22: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOWUP

More information

SURGICAL CARE IMPROVEMENT PROJECT QUALITY MEASURES

SURGICAL CARE IMPROVEMENT PROJECT QUALITY MEASURES SURGICAL CARE IMPROVEMENT PROJECT QUALITY MEASURES Hospitals can reduce the risk of infection after surgery by making sure they provide the standard of care that is known to get the best results for most

More information

TOBACCO TREATMENT INPATIENT QUALITY MEASURES. Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015

TOBACCO TREATMENT INPATIENT QUALITY MEASURES. Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015 TOBACCO TREATMENT INPATIENT QUALITY MEASURES Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015 The Joint Commission has included a tobacco treatment measure set in their National Hospital

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic

More information

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI) Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension

More information

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT I S S U E Winter M A R C H 2 0 1 4 PracticePerspectives The National Association of Social Workers 750 First Street NE Suite 700 Washington, DC 20002-4241 SocialWorkers.org Mirean Coleman, LICSW, CT Senior

More information

Practice Director Support

Practice Director Support Table of Contents AOA MORE Enrollment 2 AOA MORE Practice Director Version.2-3 Practice Director Update Instructions. 3-4 AOA Management Setup....5-6 AOA Submission Trial and Production Submission Run

More information

What is Quitline Iowa?

What is Quitline Iowa? CONTENTS: What is Quitline Iowa? 0 A telephone counseling helpline for tobacco-use cessation. Free to all residents of the state of Iowa Open Monday-Thursday 7:00am 12:00am / Friday 7:00am 9:00pm / Saturday

More information

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL)

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL) OCHSNER PHYSICIAN PARTNERS PQRS Measures by Specialty (FINAL) Allergy and Immunology 2. Asthma: Pharmacologic Therapy for Persistent Asthma - Ambulatory Care Setting (PQRS 53) 3. Patients aged 18 years

More information